Oxford University Press, Clinical Infectious Diseases, 10(71), p. 2710-2712, 2020
DOI: 10.1093/cid/ciaa474
Full text: Unavailable
Abstract Among 279 patients within a large healthcare system in San Francisco, event-driven HIV pre-exposure prophylaxis using a 2–1–1 regimen was a desirable alternative to daily dosing. Problems with adherence, planning sex in advance, or side effects were infrequent (13.9%). We found no new HIV infections over 136 person-years of follow-up.